Intracavernous injection in the treatment of erectile dysfunction after radical prostatectomy: an observational study
São Paulo med. j
; São Paulo med. j;119(4): 135-137, July 2001.
Article
em En
| LILACS
| ID: lil-302318
Biblioteca responsável:
BR1.1
ABSTRACT
CONTEXT Despite the recent improvements in performing radical retropubic prostatectomy that have led to a considerable decrease in the complication rate, erectile dysfunction still represents a major problem. Moreover, less invasive treatment options that are emerging for erectile dysfunction have not shown satisfactory results in managing these patients. OBJECTIVE:
To study the efficacy and side effects of self-injection therapy in the treatment of men who had become impotent after undergoing radical prostatectomy due to prostate cancer, over a study period of 96 months.DESIGN:
Observational study.SETTING:
University Referral Center.PARTICIPANTS:
168 patients with erectile dysfunction, aged 43 to 78 years old, who underwent radical retropubic prostatectomy due to localized prostate cancer. PROCEDURES The patients were treated with self-injection therapy using papaverine, phentolamine and prostaglandin E1, at home.RESULTS:
This study showed an acceptable 94.6 percent success rate, with no life-threatening complications. In addition to this, our series presented a 13.1 percent cure rate with this therapy.CONCLUSION:
Self-injection therapy with papaverine, phentolamine and prostaglandin E1 is effective and safe in the treatment of erectile dysfunction after radical prostatectomy
Texto completo:
1
Índice:
LILACS
Assunto principal:
Prostatectomia
/
Vasodilatadores
/
Disfunção Erétil
Tipo de estudo:
Observational_studies
Limite:
Adult
/
Humans
/
Male
Idioma:
En
Revista:
São Paulo med. j
Assunto da revista:
Cirurgia Geral
/
Cincia
/
Ginecologia
/
MEDICINA
/
Medicina Interna
/
Obstetr¡cia
/
Pediatria
/
Sa£de Mental
/
Sa£de P£blica
Ano de publicação:
2001
Tipo de documento:
Article